(1S-Endo)-5-(4-Chloro-3-methylphenyl)-1-((4-methylphenyl)methyl)-N-(1,3,3-trimethylbicyclo(2.2.1)hept-2-yl)-1H-pyrazole-3-carboxamide (BioDeep_00001029234)
代谢物信息卡片
(1S-Endo)-5-(4-Chloro-3-methylphenyl)-1-((4-methylphenyl)methyl)-N-(1,3,3-trimethylbicyclo(2.2.1)hept-2-yl)-1H-pyrazole-3-carboxamide
化学式: C29H34ClN3O (475.23902640000006)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC1=CC=C(C=C1)CN2C(=CC(=N2)C(=O)NC3C(C4CCC3(C4)C)(C)C)C5=CC(=C(C=C5)Cl)C
InChI: InChI=1S/C29H34ClN3O/c1-18-6-8-20(9-7-18)17-33-25(21-10-11-23(30)19(2)14-21)15-24(32-33)26(34)31-27-28(3,4)22-12-13-29(27,5)16-22/h6-11,14-15,22,27H,12-13,16-17H2,1-5H3,(H,31,34)/t22-,27-,29+/m1/s1
数据库引用编号
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Stewart Christie, Vladimir Zagorodnyuk. CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder.
American journal of physiology. Renal physiology.
2021 05; 320(5):F859-F865. doi:
10.1152/ajprenal.00065.2021. [PMID: 33749323] - Alba Huerga-Gómez, Tania Aguado, Aníbal Sánchez-de la Torre, Ana Bernal-Chico, Carlos Matute, Susana Mato, Manuel Guzmán, Ismael Galve-Roperh, Javier Palazuelos. Δ9 -Tetrahydrocannabinol promotes oligodendrocyte development and CNS myelination in vivo.
Glia.
2021 03; 69(3):532-545. doi:
10.1002/glia.23911. [PMID: 32956517] - Ming Tang, Xu Cao, Kun Zhang, You Li, Quan-You Zheng, Gui-Qing Li, Qian-Hui He, Shu-Jing Li, Gui-Lian Xu, Ke-Qin Zhang. Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression.
Cell death & disease.
2018 05; 9(6):601. doi:
10.1038/s41419-018-0666-y. [PMID: 29789558] - Chrysoula C Stachtari, Olympia N Thomareis, Georgia G Tsaousi, Konstantinos A Karakoulas, Foteini I Chatzimanoli, Stavros A Chatzopoulos, Dimitrios G Vasilakos. Interaction of a Cannabinoid-2 Agonist With Tramadol on Nociceptive Thresholds and Immune Responses in a Rat Model of Incisional Pain.
American journal of therapeutics.
2016 Nov; 23(6):e1484-e1492. doi:
10.1097/mjt.0000000000000131. [PMID: 25370921] - Jocelijn Meijerink, Mieke Poland, Michiel G J Balvers, Pierluigi Plastina, Carolien Lute, Jvalini Dwarkasing, Klaske van Norren, Renger F Witkamp. Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages.
British journal of pharmacology.
2015 Jan; 172(1):24-37. doi:
10.1111/bph.12747. [PMID: 24780080] - Rentian Feng, Christine A Milcarek, Xiang-Qun Xie. Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion.
BMC pharmacology & toxicology.
2014 Jun; 15(?):30. doi:
10.1186/2050-6511-15-30. [PMID: 24913620] - Valerio Chiurchiù, Mirko Lanuti, Giuseppina Catanzaro, Filomena Fezza, Cinzia Rapino, Mauro Maccarrone. Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor.
Atherosclerosis.
2014 Mar; 233(1):55-63. doi:
10.1016/j.atherosclerosis.2013.12.042. [PMID: 24529123] - Alline C Campos, Zaira Ortega, Javier Palazuelos, Manoela V Fogaça, Daniele C Aguiar, Javier Díaz-Alonso, Silvia Ortega-Gutiérrez, Henar Vázquez-Villa, Fabricio A Moreira, Manuel Guzmán, Ismael Galve-Roperh, Francisco S Guimarães. The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system.
The international journal of neuropsychopharmacology.
2013 Jul; 16(6):1407-19. doi:
10.1017/s1461145712001502. [PMID: 23298518] - Rebecca M Craft, Alexa A Wakley, Kimberly T Tsutsui, Jillian D Laggart. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
The Journal of pharmacology and experimental therapeutics.
2012 Mar; 340(3):787-800. doi:
10.1124/jpet.111.188540. [PMID: 22182934] - Lankun Wu, Eric W Rowe, Ksenija Jeftinija, Srdija Jeftinija, Ludmila Rizshsky, Basil J Nikolau, Jodi McKay, Marian Kohut, Eve Syrkin Wurtele. Echinacea-induced cytosolic Ca2+ elevation in HEK293.
BMC complementary and alternative medicine.
2010 Nov; 10(?):72. doi:
10.1186/1472-6882-10-72. [PMID: 21092239] - M V Catani, V Gasperi, G Catanzaro, S Baldassarri, A Bertoni, F Sinigaglia, L Avigliano, M Maccarrone. Human platelets express authentic CB₁ and CB₂ receptors.
Current neurovascular research.
2010 Nov; 7(4):311-8. doi:
10.2174/156720210793180774. [PMID: 20854251] - Maria Teresa Cencioni, Valerio Chiurchiù, Giuseppina Catanzaro, Giovanna Borsellino, Giorgio Bernardi, Luca Battistini, Mauro Maccarrone. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.
PloS one.
2010 Jan; 5(1):e8688. doi:
10.1371/journal.pone.0008688. [PMID: 20098669] - Hironobu Fukuda, Toshio Abe, Shigemi Yoshihara. The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways.
International archives of allergy and immunology.
2010; 152(3):295-300. doi:
10.1159/000283042. [PMID: 20150748] - Nuria Olea-Herrero, Diana Vara, Sophie Malagarie-Cazenave, Inés Díaz-Laviada. The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.
Journal of immunotoxicology.
2009 Dec; 6(4):249-56. doi:
10.3109/15476910903241696. [PMID: 19908944] - Lamont Booker, Pattipati S Naidu, Raj K Razdan, Anu Mahadevan, Aron H Lichtman. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
Drug and alcohol dependence.
2009 Nov; 105(1-2):42-7. doi:
10.1016/j.drugalcdep.2009.06.009. [PMID: 19679411] - Betty B Yao, Gin Hsieh, Anthony V Daza, Yihong Fan, George K Grayson, Tiffany Runyan Garrison, Odile El Kouhen, Bradley A Hooker, Madhavi Pai, Erica J Wensink, Anita K Salyers, Prasant Chandran, Chang Z Zhu, Chengmin Zhong, Keith Ryther, Megan E Gallagher, Chih-Liang Chin, Ann E Tovcimak, Vincent P Hradil, Gerard B Fox, Michael J Dart, Prisca Honore, Michael D Meyer. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
The Journal of pharmacology and experimental therapeutics.
2009 Jan; 328(1):141-51. doi:
10.1124/jpet.108.145011. [PMID: 18931146] - M Dalle Carbonare, E Del Giudice, A Stecca, D Colavito, M Fabris, A D'Arrigo, D Bernardini, M Dam, A Leon. A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story...
Journal of neuroendocrinology.
2008 May; 20 Suppl 1(?):26-34. doi:
10.1111/j.1365-2826.2008.01689.x. [PMID: 18426496] - Yong-Yao Cui, Bruno D'Agostino, Paul-André Risse, Guiseppina Marrocco, Emmanuel Naline, Yong Zhang, Hong-Zhuan Chen, Olivier Finance, Murielle Rinaldi-Carmona, Francesco Rossi, Charles Advenier. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
European journal of pharmacology.
2007 Nov; 573(1-3):206-13. doi:
10.1016/j.ejphar.2007.06.040. [PMID: 17643417] - A Thomas, G L Baillie, A M Phillips, R K Razdan, R A Ross, R G Pertwee. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
British journal of pharmacology.
2007 Mar; 150(5):613-23. doi:
10.1038/sj.bjp.0707133. [PMID: 17245363] - Michelle Roche, Michael Diamond, John P Kelly, David P Finn. In vivo modulation of LPS-induced alterations in brain and peripheral cytokines and HPA axis activity by cannabinoids.
Journal of neuroimmunology.
2006 Dec; 181(1-2):57-67. doi:
10.1016/j.jneuroim.2006.08.001. [PMID: 17011047] - Erica J Carrier, John A Auchampach, Cecilia J Hillard. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.
Proceedings of the National Academy of Sciences of the United States of America.
2006 May; 103(20):7895-900. doi:
10.1073/pnas.0511232103. [PMID: 16672367] - Ester Fride, Datta Ponde, Aviva Breuer, Lumir Hanus. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Neuropharmacology.
2005 Jun; 48(8):1117-29. doi:
10.1016/j.neuropharm.2005.01.023. [PMID: 15910887] - Sándor Bátkai, Pál Pacher, Douglas Osei-Hyiaman, Svetlana Radaeva, Jie Liu, Judith Harvey-White, László Offertáler, Ken Mackie, M Audrey Rudd, Richard D Bukoski, George Kunos. Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension.
Circulation.
2004 Oct; 110(14):1996-2002. doi:
10.1161/01.cir.0000143230.23252.d2. [PMID: 15451779] - Catherine A Newton, Tangying Lu, Stanley J Nazian, Izabella Perkins, Herman Friedman, Thomas W Klein. The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2.
Journal of leukocyte biology.
2004 Oct; 76(4):854-61. doi:
10.1189/jlb.0304184. [PMID: 15258190] - Zsuzsanna Helyes, József Németh, Márta Thán, Kata Bölcskei, Erika Pintér, János Szolcsányi. Inhibitory effect of anandamide on resiniferatoxin-induced sensory neuropeptide release in vivo and neuropathic hyperalgesia in the rat.
Life sciences.
2003 Sep; 73(18):2345-53. doi:
10.1016/s0024-3205(03)00651-9. [PMID: 12941436] - Brad L Upham, Alisa M Rummel, Joseph M Carbone, James E Trosko, Yanli Ouyang, Robert B Crawford, Norbert E Kaminski. Cannabinoids inhibit gap junctional intercellular communication and activate ERK in a rat liver epithelial cell line.
International journal of cancer.
2003 Mar; 104(1):12-8. doi:
10.1002/ijc.10899. [PMID: 12532414] - Yanlin Jia, Robbie L McLeod, Xin Wang, Leonard E Parra, Robert W Egan, John A Hey. Anandamide induces cough in conscious guinea-pigs through VR1 receptors.
British journal of pharmacology.
2002 Nov; 137(6):831-6. doi:
10.1038/sj.bjp.0704950. [PMID: 12411414] - V Ralevic, D A Kendall, J C Jerman, D N Middlemiss, D Smart. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
European journal of pharmacology.
2001 Jul; 424(3):211-9. doi:
10.1016/s0014-2999(01)01153-0. [PMID: 11672565] - A S Rice. Cannabinoids and pain.
Current opinion in investigational drugs (London, England : 2000).
2001 Mar; 2(3):399-414. doi:
". [PMID: 11575713] - M MacCarrone, M Bari, A Menichelli, E Giuliani, D Del Principe, A Finazzi-Agrò. Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor.
European journal of biochemistry.
2001 Feb; 268(3):819-25. doi:
10.1046/j.1432-1327.2001.01942.x. [PMID: 11168423] - S R Smith, C Terminelli, G Denhardt. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice.
The Journal of pharmacology and experimental therapeutics.
2000 Apr; 293(1):136-50. doi:
NULL. [PMID: 10734163] - G Griffin, Q Tao, M E Abood. Cloning and pharmacological characterization of the rat CB(2) cannabinoid receptor.
The Journal of pharmacology and experimental therapeutics.
2000 Mar; 292(3):886-94. doi:
. [PMID: 10688601] - P Valk, S Verbakel, M von Lindern, B Löwenberg, R Delwel. Enhancement of erythropoietin-stimulated cell proliferation by Anandamide correlates with increased activation of the mitogen-activated protein kinases ERK1 and ERK2.
The hematology journal : the official journal of the European Haematology Association.
2000; 1(4):254-63. doi:
10.1038/sj.thj.6200036. [PMID: 11920199] - J M Derocq, M Bouaboula, J Marchand, M Rinaldi-Carmona, M Ségui, P Casellas. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
FEBS letters.
1998 Apr; 425(3):419-25. doi:
10.1016/s0014-5793(98)00275-0. [PMID: 9563506]